Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne
This study has been completed.
Study NCT00211497   Information provided by MIGENIX Inc.
First Received: September 13, 2005   No Changes Posted

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2003
  Estimated Primary Completion Date: No date given